IP Library › Assignment 022841/0844
Patent Assignment
Reel/Frame 022841/0844

Assignment of Assignor's Interest

Recorded: 2009-06-18 Pages: 8
Assignor
4325231 CANADA INC.
Executed: 2007-07-10
Assignee
GENESENSE TECHNOLOGIES INC.
2 MERIDIAN ROAD, TORONTO, ONTARIO, M9W 4Z7, CANADA
Covered Property (1)
Use of Interleukin 17E for the Treatment of Cancer
Patent: 8,287,851 →
Application: 11/817,914 →
Publication: US 2011/0158936
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 10, 2009
From: WRIGHT, JIM A.; YOUNG, AIPING H.; LEE, YOON; CAO, MING YU
To: LORUS THERAPEUTICS, INC.
Reel/Frame 022807/0149 →
Assignment of Assignor's Interest Jun 15, 2009
From: LORUS THERAPEUTICS INC.
To: 4325231 CANADA INC.
Reel/Frame 022823/0684 →
Assignment of Assignor's Interest Aug 26, 2009
From: GENESENSE TECHNOLOGIES INC.
To: LORUS THERAPEUTICS INC.
Reel/Frame 023145/0289 →
Change of Name Sep 22, 2014
From: LORUS THERAPEUTICS INC.
To: APTOSE BIOSCIENCES INC.
Reel/Frame 033793/0620 →